Reports and Payments in General. With respect to the Licensed Product(s) in the Partner Territory, each Party shall report to the other Party, within [*] days after the end of each quarter, Net Sales (in the case of ZAI) and Allowable Expenses incurred by such Party (including any Allowable Expenses incurred by a Party prior to Regulatory Approval of such Product) as set forth in Section 6.2(g) for such Licensed Product(s) during such quarter in the Partner Territory. Each such report shall specify in reasonable detail all deductions allowed in the calculation of such Net Sales and all expenses included in Allowable Expenses, and, if requested by a Party, any invoices or other supporting documentation for any payments to a Third Party that individually exceed [*] or collectively exceed [*] (or such other amount approved by the JCC) shall be promptly provided. Within [*] days after the end of each quarter (or for the last quarter in a year, [*] days after the end of such quarter), ZAI shall reconcile all Net Sales and Allowable Expenses to ascertain whether there is an Operating Profit or an Operating Loss and payments shall be made, and shall provide a report to BMS setting forth in reasonable detail such calculation of Operating Profit or Operating Loss, and make payment or provide invoice to BMS for any reconciling payment as set forth in paragraphs (i) and (ii) below, as applicable. [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amended.
Appears in 2 contracts
Samples: License Agreement (Zai Lab LTD), License Agreement (Zai Lab LTD)
Reports and Payments in General. With respect to the Licensed Product(s) in the Partner Territorya Co-Promotion Product, or a Co-Developed Product for which Exelixis has not yet elected whether to exercise its Co-Promotion Option, each Party shall report to the other Party, within [*] days after the end of each quarter, with regard to Net Sales (in the case of ZAI) and Allowable Expenses incurred by such Party (including any Allowable Expenses incurred by a Party prior to Regulatory Approval of such Product) as set forth in Section 6.2(g) for such Licensed Product(s) Product during such quarter in the Partner Territory. U.S. Each such report shall specify in reasonable detail all deductions allowed in the calculation of such Net Sales and all expenses included in Allowable Expenses, and, if requested by a Party, any invoices or other supporting documentation for any payments to a Third Party that individually exceed [*] or collectively exceed [*] (or such other amount approved by the JCCJFC) shall be promptly provided. Within [*] days after the end of each quarter (or for the last quarter in a year, [*] days after the end of such quarter), ZAI the Parties shall reconcile all Net Sales and Allowable Expenses to ascertain whether there is an Operating Profit or an Operating Loss and payments shall be made, and shall provide a report to BMS setting forth in reasonable detail such calculation of Operating Profit or Operating Loss, and make payment or provide invoice to BMS for any reconciling payment made as set forth in paragraphs (i) and (ii) below, as applicable. [*] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 24b-2 of the Securities Exchange Act of 19331934, as amended.
Appears in 1 contract
Reports and Payments in General. With respect to the Licensed Product(s(i) in the Partner Territory, each Each Party shall report to the other Party, within [*] thirty (30) days after the end of each quarterQuarter, the Net Sales (in the case of ZAI) and Allowable Expenses incurred by such Party for each Collaboration Compound or Product during such Quarter (including any or in the case of COLLABORATOR, the corresponding PFIZER Quarter) in each country in the Territory in a manner sufficient to enable the other Party to comply with its financial reporting requirements and on a line item basis consistent with the budgetary line items set forth in the Pre‑Launch Commercialization Plan and Budget or Annual Commercialization Plan and Budget, as applicable (except that the first such report shall report with respect to Allowable Expenses incurred by a Party prior to Regulatory Approval from the Cost Sharing Effective Date through the end of such Product) Quarter or PFIZER Quarter, as set forth in Section 6.2(g) for such Licensed Product(s) during such quarter in the Partner Territoryapplicable). Each such Such report shall specify in reasonable detail all deductions allowed in the calculation of such Net Sales and all expenses included in Allowable ExpensesExpenses for such Collaboration Compound or Product, and, if requested by a Party, any invoices or other supporting documentation for any payments to a Third Party in respect of Allowable Expenses that individually exceed [*] or collectively exceed [*] (or such other amount approved as may be specified by the JCCJEC from time to time) shall be promptly provided. Within [*] provided not more than thirty (30) days after the end receipt of each quarter (or for the last quarter in a year, [*] days after the end of such quarter), ZAI shall reconcile all Net Sales and Allowable Expenses to ascertain whether there is an Operating Profit or an Operating Loss and payments shall be made, and shall provide a report to BMS setting forth in reasonable detail such calculation of Operating Profit or Operating Loss, and make payment or provide invoice to BMS for any reconciling payment as set forth in paragraphs (i) and (ii) below, as applicablerequest therefor. 112 [*] = Certain Portions of this exhibit have been omitted pursuant to a confidential information contained in treatment request. An unredacted version of this document, marked by brackets, exhibit has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 406 of the Securities Act of 1933, as amendedCommission.
Appears in 1 contract